These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28671047)

  • 1. The role of Capon in multiple myeloma.
    Shen Y; Liu H; Gu S; Wei Z; Liu H
    Tumour Biol; 2017 Jul; 39(7):1010428317713674. PubMed ID: 28671047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.
    Shen Y; Sun Y; Zhang L; Liu H
    Tumour Biol; 2017 Jun; 39(6):1010428317703941. PubMed ID: 28653881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
    Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
    Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 5. Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway.
    Gao S; Wang J; Zhang T; Liu G; Jin L; Ji D; Wang P; Meng Q; Zhu Y; Yu R
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    Liu H; Ding L; Shen Y; Zhong F; Wang Q; Xu X
    Int J Biol Macromol; 2016 Oct; 91():115-22. PubMed ID: 27189701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance.
    Chen R; Zhao H; Wu D; Zhao C; Zhao W; Zhou X
    Oncotarget; 2016 Nov; 7(45):73101-73113. PubMed ID: 27683032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
    Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
    Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
    Nefedova Y; Landowski TH; Dalton WS
    Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
    Yanamandra N; Colaco NM; Parquet NA; Buzzeo RW; Boulware D; Wright G; Perez LE; Dalton WS; Beaupre DM
    Clin Cancer Res; 2006 Jan; 12(2):591-9. PubMed ID: 16428505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
    Azab F; Vali S; Abraham J; Potter N; Muz B; de la Puente P; Fiala M; Paasch J; Sultana Z; Tyagi A; Abbasi T; Vij R; Azab AK
    Br J Haematol; 2014 Apr; 165(1):89-101. PubMed ID: 24405121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CAPON and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury.
    Chen M; Cheng C; Yan M; Niu S; Gao S; Shi S; Liu H; Qin Y; Shen A
    J Mol Neurosci; 2008; 34(1):89-100. PubMed ID: 18157660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
    Moschetta M; Basile A; Ferrucci A; Frassanito MA; Rao L; Ria R; Solimando AG; Giuliani N; Boccarelli A; Fumarola F; Coluccia M; Rossini B; Ruggieri S; Nico B; Maiorano E; Ribatti D; Roccaro AM; Vacca A
    Clin Cancer Res; 2013 Aug; 19(16):4371-82. PubMed ID: 23804425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).
    Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S
    Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.
    Morgan JJ; McAvera RM; Crawford LJ
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.